NUTX insider transaction filings
Nutex Health Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-18. Screen NUTX transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 5 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing by 1 insider — 203 shares, $43,493 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: sale of 203 shares @ $214.25 ($43,493) by Saunders Scott J, filed 2026-09-18.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Saunders Scott J — Director | 2 | — | 1 leg · 203 sh · $43,493 | 1 |
| Grenas Cheryl Yvonne — Director | 1 | — | — | 1 |
| Jaumot Frank E — Director | 1 | — | — | 1 |
| Reed Michael Lee — Director | 1 | — | — | 1 |
Recent Form 4 filings — Nutex Health Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-18 | 4 | Saunders Scott J — Director | Sale (S): 203 @ $214.25 | EDGAR |
| 2026-08-03 | 4 | Jaumot Frank E — Director | Option exercise (M): 603 @ $0 | EDGAR |
| 2026-08-03 | 4 | Grenas Cheryl Yvonne — Director | Option exercise (M): 603 @ $0 | EDGAR |
| 2026-08-03 | 4 | Saunders Scott J — Director | Option exercise (M): 603 @ $0 | EDGAR |
| 2026-08-03 | 4 | Reed Michael Lee — Director | Option exercise (M): 603 @ $0 | EDGAR |
| 2026-06-04 | 4 | Spears Kelvin — Director | Other (J): 2,519 @ $0 | EDGAR |
| 2026-05-29 | 4 | Vo Thomas T. — Chief Executive Officer, Director | Other (J): 75,747 @ $0 | EDGAR |
| 2026-04-24 | 4 | Saunders Scott J — Director | Grant/award (A): 823 (derivative) @ $0 | EDGAR |
| 2026-04-24 | 4 | Reed Michael Lee — Director | Grant/award (A): 823 (derivative) @ $0 | EDGAR |
| 2026-04-24 | 4 | Grenas Cheryl Yvonne — Director | Grant/award (A): 823 (derivative) @ $0 | EDGAR |
| 2026-04-24 | 4 | Jaumot Frank E — Director | Grant/award (A): 823 (derivative) @ $0 | EDGAR |
| 2026-04-10 | 4 | Vo Thomas T. — Chief Executive Officer, Director | Other (J): 184,071 @ $0 · Option exercise (M): 4,841 (derivative) @ $0 | EDGAR |
| 2026-03-24 | 4 | Bamburg Wesley Shane — Chief Operating Officer | Option exercise (M): 2,411 (derivative) @ $0 | EDGAR |
| 2026-03-23 | 4 | Hosseinion Warren — President, Director | Purchase (P): 252 @ $94.07 · Option exercise (M): 3,656 (derivative) @ $0 | EDGAR |
| 2026-03-23 | 4 | Jaumot Frank E — Director | Purchase (P): 150 @ $93.56 | EDGAR |
| 2026-03-18 | 4 | Spears Kelvin — Director | Purchase (P): 10 @ $94.46 · Option exercise (M): 116 (derivative) @ $0 | EDGAR |
| 2026-03-16 | 4 | Montgomery Pamela W. — Chief Legal Officer-Healthcare | Purchase (P): 79 @ $88.87 · Option exercise (M): 1,523 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Spears Kelvin — Director | Option exercise (M): 183 @ $0 · Tax withholding (F): 82 @ $86.22 · Option exercise (M): 116 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Bates Jon Christian — Chief Financial Officer | Option exercise (M): 2,667 @ $0 · Option exercise (M): 1,694 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Vo Thomas T. — Chief Executive Officer, Director | Option exercise (M): 8,334 @ $0 · Tax withholding (F): 3,017 @ $86.22 · Option exercise (M): 4,841 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Chang Michael L. — Chief Medical Officer | Option exercise (M): 2,084 @ $0 · Tax withholding (F): 769 @ $86.22 · Option exercise (M): 1,936 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Montgomery Pamela W. — Chief Legal Officer-Healthcare | Option exercise (M): 2,084 @ $0 · Tax withholding (F): 776 @ $86.22 · Option exercise (M): 1,525 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Luqman Elisa V — Chief Legal Officer - SEC | Option exercise (M): 2,084 @ $0 · Tax withholding (F): 784 @ $86.22 · Option exercise (M): 1,525 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Hosseinion Warren — President, Director | Option exercise (M): 6,293 @ $0 · Tax withholding (F): 3,274 @ $86.22 · Option exercise (M): 3,656 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Saunders Scott J — Director | Grant/award (A): 603 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Reed Michael Lee — Director | Grant/award (A): 603 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Grenas Cheryl Yvonne — Director | Grant/award (A): 603 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Jaumot Frank E — Director | Grant/award (A): 603 (derivative) @ $0 | EDGAR |
| 2025-11-28 | 4 | Bates Jon Christian — Chief Financial Officer | Purchase (P): 750 @ $136.71 | EDGAR |
| 2025-04-14 | 4 | Bates Jon Christian — Chief Financial Officer | Option exercise (M): 111 @ $0 · Option exercise (M): 1,500 @ $0 · Purchase (P): 1,000 @ $81.81 · Option exercise (M): 3,500 (derivative) @ $0 | EDGAR |
| 2025-04-14 | 4 | Spears Kelvin — Director | Option exercise (M): 143 @ $0 · Tax withholding (F): 34 @ $72.10 · Option exercise (M): 120 (derivative) @ $0 | EDGAR |
| 2025-04-14 | 4 | DeTillio Joshua — Chief Operating Officer | Option exercise (M): 2,125 @ $0 · Tax withholding (F): 452 @ $72.10 · Option exercise (M): 5,950 (derivative) @ $0 | EDGAR |
| 2025-04-14 | 4 | Montgomery Pamela W. — Chief Legal Officer-Healthcare | Option exercise (M): 111 @ $0 · Tax withholding (F): 24 @ $72.10 · Option exercise (M): 1,250 @ $0 · Tax withholding (F): 266 @ $72.10 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2025-04-14 | 4 | Chang Michael L. — Chief Medical Officer | Option exercise (M): 1,250 @ $0 · Tax withholding (F): 266 @ $72.10 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2025-04-14 | 4 | Vo Thomas T. — Chief Executive Officer, Director | Option exercise (M): 5,000 @ $0 · Tax withholding (F): 895 @ $72.10 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-04-14 | 4 | Luqman Elisa V — Chief Legal Officer - SEC | Option exercise (M): 1,250 @ $0 · Tax withholding (F): 266 @ $72.10 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2025-04-14 | 4 | Hosseinion Warren — President, Director | Option exercise (M): 3,776 @ $0 · Tax withholding (F): 1,072 @ $72.10 · Option exercise (M): 7,551 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | Vo Thomas T. — Chief Executive Officer, Director | Gift (G): 5,000 @ $0 | EDGAR |
| 2024-10-07 | 4/A | Dogan Meeshanthini — Chief Executive Officer, Director | Purchase (P): 68,965 @ $0.29 | EDGAR |
| 2024-09-23 | 4/A | Dogan Timur — Chief Technology Officer | Purchase (P): 68,965 @ $0.29 | EDGAR |
| 2024-08-26 | 4 | Bates Jon Christian — Chief Financial Officer | Purchase (P): 1,350 @ $21.46 | EDGAR |
| 2024-08-21 | 4 | DeTillio Joshua — Chief Operating Officer | Purchase (P): 1,300 @ $17.85 · Purchase (P): 575 @ $17.40 | EDGAR |
| 2024-07-15 | 4 | Vo Thomas T. — Chief Executive Officer, Director | Grant/award (A): 22,709 | EDGAR |
| 2024-06-28 | 4 | Montgomery Pamela W. — Chief Legal Officer-Healthcare | Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2024-06-28 | 4 | Chang Michael L. — Chief Medical Officer | Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2024-06-28 | 4 | DeTillio Joshua — Chief Operating Officer | Grant/award (A): 63,750 (derivative) @ $0 | EDGAR |
| 2024-06-28 | 4 | Bates Jon Christian — Chief Financial Officer | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-06-28 | 4 | Vo Thomas T. — Chief Executive Officer, Director | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-06-28 | 4 | Hosseinion Warren — President, Director | Grant/award (A): 113,265 (derivative) @ $0 | EDGAR |
| 2024-06-28 | 4/A | Hosseinion Warren — President, Director | Grant/award (A): 113,265 (derivative) @ $0 | EDGAR |
Recent 8-K events — Nutex Health Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-18 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-11 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-31 | 8-K | ? | EDGAR |
| 2026-08-24 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-20 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-13 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2026-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-23 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NUTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →